Compare Definium Therapeutics Inc. Common Shares (DFTX) vs LYFT Inc (LYFT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs LYFT Inc — how do they compare? Definium Therapeutics Inc. Common Shares trades at $37.05 (market cap $4.59B), while LYFT Inc trades at $16.21 (market cap $6.11B). The key difference: LYFT Inc is the larger of the two by market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, LYFT Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and LYFT Inc for 47 Days on average.
| DFTX | LYFT | |
|---|---|---|
Market Cap | $4.59B | $6.11B |
Volume | 2,103,937 | 13,504,560 |
Sector | Health | Technology |
52-Week High | $48.45 | $24.57 |
52-Week Low | $10.68 | $12.65 |
Typical Hold Time | 0 Days | 47 Days |
Enterprise Value | $3.55B | $5.57B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Lyft (LYFT) trades at $16.22, up 3.97% with a bullish technical signal. The company shows strong profitability with 45.52% gross margins and 42.32% net income margin, though recent earnings missed expectations. Revenue growth continues from $4.1B in 2022 to $6.32B in 2025. Recent developments include European expansion and a $272.5M legal settlement. The stock trades below the $18.07 consensus price target with 22 buy, 35 hold, and 3 sell ratings.
Lyft presents a mixed outlook with strong cash flow generation and expanding operations balanced against recent earnings misses and competitive pressures. The bullish technical setup and below-consensus pricing suggest potential upside, but investors face risks from driver classification lawsuits, market volatility, and execution challenges in new markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About LYFT Inc
Lyft is the second-largest ride-sharing service provider in the U.S., connecting riders and drivers over the Lyft app. Lyft recently entered the Canadian market in an effort to expand its market outside the U.S. Incorporated in 2013, Lyft offers a variety of rides via private vehicles, including traditional private rides, shared rides, and luxury ones. Besides ride-share, Lyft also has entered the bike- and scooter-share market to bring multimodal transportation options to users.
Read more on LYFT →
